Caron Kerr

Statistics

Publications

Citations

341

H-Index

Active since

2002

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Walter Reed Army Institute of Research

Caron Kerr is an author at GlaxoSmithKline (United Kingdom) specializing in infectious disease pharmacotherapy, infectious diseases, and inhaled therapies.

Publications per year

2002–2009

Publications

Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within Households

Arnold S. Monto, Michael E. Pichichero, Steve J. Blanckenberg et al. · The Journal of Infectious Diseases · 2002 · 149 citations

Public Health, Infectious Diseases, Pharmacotherapy +14

Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune Subjects

Peter Nasveld, Michael D. Edstein, Mark Reid et al. · Antimicrobial Agents and Chemotherapy · 2009 · 122 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +12

Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with Influenza

Tuomo Puhakka, H. Lehti, Raija Vainionpää et al. · Scandinavian Journal of Infectious Diseases · 2003 · 38 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

A Randomized, Double-Blind, Safety and Tolerability Study to Assess the Ophthalmic and Renal Effects of Tafenoquine 200 mg Weekly versus Placebo for 6 Months in Healthy Volunteers

Kevin J. Leary, Michael A. Riel, Michael J. Roy et al. · American Journal of Tropical Medicine and Hygiene · 2009 · 32 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

1–4 of 4